Frontlight ResearchEarly access
Trial site
Salvia Lekston I Madej Sp. J.
- 6running trials
- 7closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Obesity8 trials
- Type 2 diabetes6 trials
- Chronic kidney disease2 trials
- High blood pressure2 trials
- Type 1 diabetes2 trials
- Heart failure1 trial
- Phase
- Phase 312 trials
- Phase 21 trial
- Status
- Completed7 trials
- Recruiting5 trials
- Active, not recruiting1 trial
- Lead sponsor
- AstraZeneca3 trials
- Amgen Inc.2 trials
- Boehringer Ingelheim2 trials
- Eli Lilly and Company2 trials
- Novo Nordisk A/S2 trials
- and 2 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity3 recruiting
- Type 2 diabetes3 recruiting
- High blood pressure2 recruiting
- Chronic kidney disease1 recruiting
- Heart failure1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Completed
Completed
Completed
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
Completed
Active, not recruiting
A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight
Completed
A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia.
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026